Butaperazine
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.450 |
| Chemical and physical data | |
| Formula | C24H31N3OS |
| Molar mass | 409.59 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Butaperazine (Repoise, Tyrylen) is a typical antipsychotic of the phenothiazine class. It was approved in 1967, and possibly discontinued in the 1980s.
Synthesis
2-Butyrylphenothiazine [25244-91-1] (1) is the requisite starting material for carrying out the procedure. It is prepared in a manner that is synonymous with the method used in the propiomazine and propiopromazine already discussed. The 1-(γ-chloropropyl)-4-methylpiperazine [104-16-5] (2) is prepared in the conventional way from alkylating 1-methylpiperazine and 1-Bromo-3-chloropropane. Sodamide is used to extract the 10-H thereby facilitating the nucleophilic substitution reaction. And completing the instalment of the sidechain.
See also
| |||||||||||||||||||||||||
| D1-like |
|
||||||
|---|---|---|---|---|---|---|---|
| D2-like |
|
||||||
| H1 |
|
||||
|---|---|---|---|---|---|
| H2 |
|
||||
| H3 |
|
||||
| H4 |
|
||||
| Classes | |
|---|---|
|
Antidepressants (Tricyclic antidepressants ) |
|
| Antihistamines |
|
| Antipsychotics |
|
| Anticonvulsants | |
| Anticholinergics | |
| Others |
|